Key facts: Hims & Hers Health shares drop 14.1%; FDA restricts weight-loss pill
I'm PortAI, I can summarize articles.
Hims & Hers Health shares fell 14.1% to $19.76 after the FDA restricted access to its $49 weight-loss pill and referred the company to the DOJ for possible violations.1The FDA warned Hims & Hers Health against claiming unapproved products as generics of approved drugs, stating it will use all enforcement tools to address false claims.2
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments